FIVE PRIME THERAPEUTICS INC Severance Agreements
17 Contracts & Agreements
- Executive Severance Benefit Plan and Summary Plan Description, effective November 20, 2019 (Filed With SEC on February 27, 2020)
- Executive Severance Benefits Agreement by and between the company and David V. Smith, dated as of November 26, 2018 (Filed With SEC on February 26, 2019)
- Executive Severance Benefits Agreement by and between the company and Bryan Irving, dated as of September 5, 2017 (Filed With SEC on February 26, 2019)
- Executive Severance Benefits Agreement by and between the company and Helen Collins, dated as of March 20, 2017 (Filed With SEC on February 27, 2018)
- Amendment No. 2 to the Executive Severance Benefits Agreement by and between the Company and Aron Knickerbocker, dated as of October 18, 2017 (Filed With SEC on November 6, 2017)
- Executive Severance Benefits Agreement (Filed With SEC on February 24, 2017)
- Amendment No. 1 to the Executive Severance Benefits Agreement (Filed With SEC on February 24, 2017)
- Executive Severance Benefits Agreement (Filed With SEC on February 24, 2017)
- Executive Transition and Severance Benefits Agreement (Filed With SEC on March 11, 2016)
- Amendment No. 1 to the Executive Severance Benefits Agreement (Filed With SEC on January 22, 2014)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on January 22, 2014)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on January 22, 2014)
- Amendment No. 1 to the Executive Severance BenefitsAgreement (Filed With SEC on July 26, 2013)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on July 26, 2013)
- Amendment No. 1 to the Executive Severance BenefitsAgreement (Filed With SEC on July 26, 2013)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on July 26, 2013)
- 2007 EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on July 26, 2013)
